Yu-Chu Su

776 total citations
18 papers, 605 citations indexed

About

Yu-Chu Su is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yu-Chu Su has authored 18 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Yu-Chu Su's work include Cancer Cells and Metastasis (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Yu-Chu Su is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Yu-Chu Su collaborates with scholars based in Taiwan, United Kingdom and United States. Yu-Chu Su's co-authors include Chao‐Liang Wu, Hung‐Tsung Wu, Chih‐Jen Chang, Ai‐Li Shiau, Horng-Yih Ou, Yi‐Ching Yang, Hao‐Chang Hung, Jin‐Shang Wu, Feng‐Hwa Lu and Gia-Shing Shieh and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Yu-Chu Su

18 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Chu Su Taiwan	15	297	115	114	108	108	18	605
Mei Tang China	16	335 1.1×	80 0.7×	87 0.8×	183 1.7×	133 1.2×	53	725
Shan Zhao China	14	368 1.2×	113 1.0×	105 0.9×	90 0.8×	59 0.5×	43	705
Dipti Athavale United States	14	271 0.9×	165 1.4×	178 1.6×	95 0.9×	80 0.7×	24	659
Mengyao Sun China	15	414 1.4×	125 1.1×	61 0.5×	97 0.9×	76 0.7×	36	725
Anna Tutusaus Spain	13	285 1.0×	63 0.5×	151 1.3×	72 0.7×	189 1.8×	22	702
Xuehua Sun China	17	338 1.1×	123 1.1×	245 2.1×	126 1.2×	222 2.1×	49	877
Michał Kuliński Qatar	16	415 1.4×	167 1.5×	75 0.7×	134 1.2×	53 0.5×	19	624
Zhan‐Qi Cao China	10	275 0.9×	104 0.9×	45 0.4×	112 1.0×	110 1.0×	14	528

Countries citing papers authored by Yu-Chu Su

Since Specialization

Citations

This map shows the geographic impact of Yu-Chu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Chu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Chu Su more than expected).

Fields of papers citing papers by Yu-Chu Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Chu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Chu Su. The network helps show where Yu-Chu Su may publish in the future.

Co-authorship network of co-authors of Yu-Chu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Chu Su. A scholar is included among the top collaborators of Yu-Chu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Chu Su. Yu-Chu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Su, Yu-Chu, Yi-Cheng Chen, Yau‐Lin Tseng, et al.. (2021). The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients. Cells. 10(10). 2642–2642. 3 indexed citations

Chen, Yu-Fon, et al.. (2020). Naturally derived DNA nanogels as pH- and glutathione-triggered anticancer drug carriers. Materials Science and Engineering C. 114. 111025–111025. 23 indexed citations

Shiau, Ai‐Li, Chung-Teng Wang, Yu-Chu Su, et al.. (2020). Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. Journal of Hematology & Oncology. 13(1). 62–62. 105 indexed citations

Wu, Hung‐Tsung, Lin Kang, Yu-Chu Su, et al.. (2020). Prothymosin α activates type I collagen to develop a fibrotic placenta in gestational diabetes. Clinical Science. 134(18). 2435–2445. 2 indexed citations

Feng, Yin‐Hsun, Yu-Chu Su, Chao‐Liang Wu, et al.. (2019). Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer. BMC Cancer. 19(1). 791–791. 30 indexed citations

Chen, Yu-Fon, et al.. (2019). TRAIL encapsulated to polypeptide-crosslinked nanogel exhibits increased anti-inflammatory activities in Klebsiella pneumoniae-induced sepsis treatment. Materials Science and Engineering C. 102. 85–95. 31 indexed citations

Su, Yu-Chu, Yin‐Hsun Feng, Hung‐Tsung Wu, et al.. (2018). Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression. Scientific Reports. 8(1). 6586–6586. 49 indexed citations

Chen, Yu-Fon, et al.. (2018). The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma. Leukemia & lymphoma. 60(5). 1193–1203. 21 indexed citations

Hu, Che‐Yuan, et al.. (2017). Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway. Molecules. 22(7). 1175–1175. 38 indexed citations

10.

Wu, Hung‐Tsung, Horng-Yih Ou, Hao‐Chang Hung, et al.. (2016). A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia. 59(8). 1732–1742. 68 indexed citations

11.

Shieh, Gia-Shing, Chung-Teng Wang, Yu-Chu Su, et al.. (2016). Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer. Oncotarget. 8(19). 30844–30858. 47 indexed citations

12.

Yang, Mei-Lin, Yu-Chu Su, Yi-Cheng Chen, et al.. (2015). Kallistatin Ameliorates Influenza Virus Pathogenesis by Inhibition of Kallikrein-Related Peptidase 1-Mediated Cleavage of Viral Hemagglutinin. Antimicrobial Agents and Chemotherapy. 59(9). 5619–5630. 16 indexed citations

13.

Su, Yu-Chu, Horng-Yih Ou, Hung‐Tsung Wu, et al.. (2015). Prothymosin-α Overexpression Contributes to the Development of Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 100(11). 4114–4123. 16 indexed citations

14.

Chen, Yu-Fon, Sheng‐Hung Wang, Sue-Joan Chang, et al.. (2014). Zhankuic acid A as a novel JAK2 inhibitor for the treatment of concanavalin A-induced hepatitis. Biochemical Pharmacology. 91(2). 217–230. 10 indexed citations

15.

Ou, Horng-Yih, Hung‐Tsung Wu, Feng‐Hwa Lu, et al.. (2014). Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway. Journal of Molecular Endocrinology. 53(2). 165–174. 16 indexed citations

16.

Wu, Hung‐Tsung, Feng‐Hwa Lu, Yu-Chu Su, et al.. (2014). In Vivo and In Vitro Anti-Tumor Effects of Fungal Extracts. Molecules. 19(2). 2546–2556. 46 indexed citations

17.

Wu, Hung‐Tsung, Feng‐Hwa Lu, Horng-Yih Ou, et al.. (2013). The role of Hepassocin in the development of non-alcoholic fatty liver disease. Journal of Hepatology. 59(5). 1065–1072. 69 indexed citations

18.

Shieh, Gia-Shing, Yu-Chu Su, Che‐Hsin Lee, et al.. (2012). Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer Letters. 321(1). 36–44. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Tang Breakdown of academic impact, for papers by Shan Zhao Breakdown of academic impact, for papers by Dipti Athavale Breakdown of academic impact, for papers by Mengyao Sun Breakdown of academic impact, for papers by Anna Tutusaus Breakdown of academic impact, for papers by Xuehua Sun Breakdown of academic impact, for papers by Michał Kuliński Breakdown of academic impact, for papers by Zhan‐Qi Cao